Percutaneous deep venous arterialisation for chronic limb-threatening ischaemia

1 Recommendations 1.1 Percutaneous deep venous arterialisation for chronic limb-threatening ischaemia in people with limited treatment options should only be used with special arrangements for clinical governance, consent, and audit or research. Find out what special arrangements mean on the NICE interventional procedures guidance page. 1.2 Clinicians wanting to do percutaneous deep venous arterialisation for chronic limb-threatening ischaemia should: • Inform the clinical governance leads in their healthcare organisation. • Ensure that people (and their families and carers as appropriate) understand the procedure's safety and efficacy, and any uncertainties about these. • Take account of NICE's advice on shared decision making, including NICE's information for the public. • Audit and review clinical outcomes of everyone having the procedure. The main efficacy and safety outcomes identified in this guidance can be entered into NICE's interventional procedure outcomes audit tool (for use at local discretion). • Discuss the outcomes of the procedure during their annual appraisal to reflect, learn and improve. 1.3 Healthcare organisations should: • Ensure systems are in place that support clinicians to collect and report data on outcomes and safety for everyone having this procedure. • Regularly review data on outcomes and safety for this procedure. 1.4 Further research
